July 23, 2026 — RNews

#jak inhibitor — Thursday, July 23, 2026 (1 items)

hot top new

← prev day next day →

0

Povorcitinib for hidradenitis suppurativa: the randomized, double-blind, placebo-controlled STOP-HS1 and STOP-HS2 phase 3 trials. (nature.com)

Porter ML … Zouboulis CC Nature Medicine 2026-07-23

#hidradenitis-suppurativa #jak inhibitor #clinical trial #inflammation